学习与工作经历：

2021.1~至今       山东大学临床医学院/医学融合与实践中心       教授/博士生导师                                              

2019.11~2020.7    美国耶鲁大学医学院          Associate Research Scientist/副研究员

2013.11~2019.10   美国耶鲁大学医学院                                   博士后

2008.9~2013.6     山东大学生命科学学院                                   博士

2004.9~2008.6     山东师范大学生命科学学院                               学士  

研究方向：

疾病风险基因在消化道疾病发生发展中的免疫调控机制

学术/社会兼职：

Life (Basel)的Guest editor 及审稿人，BioMed Research International、Journal of Medical Virology、Frontiers in Oncology、Frontiers in Bioengineering and Biotechnology等审稿人

中国免疫学会会员

山东免疫学会消化免疫分会会员

获奖荣誉：

Research Fellowship Award, Crohn's and Colitis Foundation of America (CCFA), 2015

本科生课程：

PBL1/PBL2/PBL3/PBL4(留学生)、人体结构与功能学PBL（齐鲁医学班）

研究生课程：

1. 82200594，国家自然科学基金青年项目，2023-2025，国家自然科学基金委，30万，主持

2. ZR2021QH198，山东省自然科学基金青年项目，2022-2024，山东省自然科学基金委，15万，主持

3. 21520082163159，山东大学齐鲁青年学者（第一层次）项目，2021-2026，120万，主持 

4. CCFA Ref. 347461，Research Fellowship Award，美国克罗恩病和结肠炎基金会(Crohn's and Colitis Foundation of America)，2016-2018，17.385万美元（约125万人民币），主持

1. Chen A, Zhao W, Li X, Sun G, Ma Z, Peng L, Shi Z, Li X,Yan J.Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme.Front. Immunol., 2022;13:840785.IF=8.786

2. Lv S, Jiang Y, Li Y, Huang R, Peng L, Ma Z, Lu N*, Lin X*,Yan J*. Comparative and Evolutionary Analysis of RIP Kinases in Immune Responses.Front Genet.2022;Epub ahead of print. *Co-corresponding author;IF=4.772

3. Huang C, Jiang Y*,Yan J*. Comparative Analyses of ACE2 and TMPRSS2 gene: Implications for the Risk for Which Vertebrate Animals Are Susceptible to SARS-CoV-2.J Med Virol. 2021; 93(9):5487-5504.*Co-corresponding author;IF=20.693

4. Kang J#,Yan J#, Zhang X, Turner J, Abraham C.Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.Gastroenterology.2020;159(3):1051-1067.#Co-first authorship;IF=33.883

5. Yan J, Pandey S, Turner J, Barnes B, Abraham C. T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation.Cell Rep.2020;31(13):107820.IF=9.995

6. Yan J, Hedl M, Abraham C.Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and IRF5 Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell Functions.J Immunol.2020;205(4):1024-1038.IF=5.426

7. Pandey S#,Yan J#, Abraham C. Reducing IRF5 expression attenuates colitis in mice but impairs the clearance of intestinal pathogens.Mucosal Immunol.2019;12(4):1065.#Contributed equally;IF=8.701

8. Yan J,Hedl M,Abraham C. An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes.J Clin Invest.2017;127(6):2192-2205.IF= 19.456